During a Senate committee hearing on Tuesday, lawmakers questioned the manufacturer of popular weight loss drugs like Ozempic and Wegovy, citing what Senator Bernie Sanders called “outrageously high” drug prices.
Categories: Abril Elfiand Pension CommitteeBernie Sanderscanadadiabetesdrug priceseducationGermanyGLP-1 agonistsHealthHealthcare systeminsulin pricinginsurance companiesKFF polllaborLars Fruergaard JørgensenlawmakersLevemirNovo NordiskOAN NewsroomObesityozempicPBMspharmacy benefit managersresearch and developmentSenate committeeTodays HeadlinesUnited KingdomUnited StatesVERMONTWegovyWeight loss drugsYale University study